Clinical trial
A Pilot Trial Examining the Safety and Efficacy of Frovatriptan as a Preemptive Treatment for Fasting-Induced Migraine Headache
NCT00440232 is registered in ClinicalTrials.gov with Thomas Jefferson University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pilot Trial Examining the Safety and Efficacy of Frovatriptan as a Preemptive Treatment for Fasting-Induced Migraine Headache
- Lead sponsor
- Thomas Jefferson University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 31, 2007
- Completion date
- September 30, 2009
- Enrollment
- 74 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
migraine